Fasken advised Mackie Research Capital Corporation. On December 2, 2020, BetterLife Pharma Inc., an emerging biotech company, closed its brokered private placement offering of special warrants,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
